• Please log in or register to access this feature.

Review Article

You have free access to this content

Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy

  1. A. M. Kuo PharmD BCPS1,
  2. J. N. Brown PharmD BCPS1,
  3. V. Clinard PharmD2

Article first published online: 26 MAR 2012

DOI: 10.1111/j.1365-2710.2012.01341.x

Issue

Journal of Clinical Pharmacy and Therapeutics

Journal of Clinical Pharmacy and Therapeutics

Volume 37, Issue 5, pages 505–509, October 2012

Additional Information

How to Cite

Kuo, A. M., Brown, J. N. and Clinard, V. (2012), Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy. Journal of Clinical Pharmacy and Therapeutics, 37: 505–509. doi: 10.1111/j.1365-2710.2012.01341.x

Author Information

  1. 1

    Department of Pharmacy Service, Durham VA Medical Center, Durham, NC

  2. 2

    Department of Pharmacy Practice, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USA

*A. M. Kuo, 508 Fulton St. (119), Durham, NC 27705, USA. Tel.: +919 286 0411 ext. 6072; fax: +919 286 6987; e-mail: kuo.alina@gmail.com

Publication History

  1. Issue published online: 3 SEP 2012
  2. Article first published online: 26 MAR 2012
  3. Received 13 July 2011, Accepted 10 February 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (510K)

References

  • 1
    Ansell J, Hirsh J, Hylek E et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008;133:160S–198S.
  • 2
    Holbrook AM, Pereira JA, Labiris R et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med, 2005;165:1095–1106.
  • 3
    Kramer P, McClain CJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med, 1981;305:1262–1264.
  • 4
    Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther, 1985;37:396–401.
  • 5
    Kramer P, Tsuru M, Cook CE, McClain CJ, Holtzman JL. Effect of influenza vaccine on warfarin anticoagulation. Clin Pharmacol Ther, 1984;35:416–418.
  • 6
    Lipsky BA, Pecoraro RE, Roben NJ, de Blaquiere P, Delaney CJ. Influenza vaccination and warfarin anticoagulation. Ann Intern Med, 1984;100:835–837.
  • 7
    Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc, 1985;33:269–272.
  • 8
    Gomolin IH. Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly. Can Med Assoc J, 1986;135:39–41.
  • 9
    Weibert RT, Lorentz SM, Norcross WA, Klauber MR, Jagger PI. Effect of influenza vaccine in patients receiving long-term warfarin therapy. Clin Pharm, 1986;5:499–503.
  • 10
    Bussey HI, Saklad JJ. Effect of influenza vaccine on chronic warfarin therapy. Drug Intell Clin Pharm, 1988;21:198–201.
  • 11
    Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med, 1995;155:1529–1531.
  • 12
    Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 “negative” trials. N Engl J Med, 1978;299:690–694.
  • 13
    Hirsh J, Bates SM. Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective. Ann Intern Med, 2001;134:409–417.
  • 14
    Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004;126(3 Suppl):204S–233S.
  • 15
    Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep, 2010;59:1–62.
  • 16
    MacCallum P, Madhani M, Mt-Isa S, Ashby D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin. Pharmacoepidemiol Drug Saf, 2007;16:786–789.
    Direct Link:
  • 17
    Paliani U, Filippucci E, Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001–2002. Haematologica 2003;88:599–600.
  • 18
    Poli D, Chiarugi L, Capanni M et al. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis, 2002;13:297–300.
  • 19
    Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA; for the Vaccine Safety Datalink investigators. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf, 2007;16:790–796.
    Direct Link:
  • 20
    Iorio A, Basileo M, Marcucci M et al. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. Arch Intern Med, 2010;170:609–616.
  • 21
    Farrow PR, Nicholson KG. Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin. J Infect, 1984;9:157–160.
  • 22
    Arnold WSG, Mehta MK, Roberts JS. Influenza vaccine and anticoagulation control in patients receiving warfarin. Br J Clin Pract, 1990;44:136–139.
  • 23
    Guillemin F. Primer: the fallacy of subgroup analysis. Nat Clin Pract Rheumatol, 2007;3:407–413.
  • 24
    Delafuente JC, Davis JA, Meuleman JR, Jones RA. Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men. Pharmacotherapy, 1998;18:631–636.
  • 25
    Casajuana J, Iglesias B, Fàbregas M et al. Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial. BMC Blood Disord, 2008;8:1.
View Full Article (HTML) Get PDF (510K)